title: Antifungal susceptibility profile of clinical Alternaria spp. identified by molecular methods.
abstract: OBJECTIVE
  To analyse the susceptibility pattern of a collection of Alternaria spp. clinical isolates.
  
  
  METHODS
  The antifungal susceptibilities of 35 isolates identified by means of sequencing the internal transcribed spacer region of rDNA were analysed by European Committee on Antimicrobial Susceptibility Testing (EUCAST) methodology.
  
  
  CONCLUSIONS
  No clear differences among the activity of antifungals against Alternaria alternata and Alternaria infectoria were detected, except for echinocandins.
authors.affiliation: Servicio de Micología, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda (Madrid), Spain. anaalastruey@isciii.es
authors.forename: Ana
authors.initials: A
authors.lastname: Alastruey-Izquierdo
authors.forename: Isabel
authors.initials: I
authors.lastname: Cuesta
authors.forename: Luis
authors.initials: L
authors.lastname: Ros
authors.forename: Emilia
authors.initials: E
authors.lastname: Mellado
authors.forename: Juan Luis
authors.initials: JL
authors.lastname: Rodriguez-Tudela
mesh_terms: D000528:Alternaria / Q000187:drug effects* / Q000302:isolation & purification; D060487:Alternariosis / Q000382:microbiology; D000935:Antifungal Agents / Q000494:pharmacology*; D001483:Base Sequence; D021903:DNA, Ribosomal Spacer / Q000235:genetics; D054714:Echinocandins / Q000494:pharmacology; D006801:Humans; D008826:Microbial Sensitivity Tests / Q000379:methods*; D017422:Sequence Analysis, DNA
chemical_list: D000935:Antifungal Agents; D021903:DNA, Ribosomal Spacer; D054714:Echinocandins